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Even if perioperative antibiotic prophylaxis represents 
a standard policy in vascular surgery, there are still 
controversial issues regarding the optimal choice of 
the antibiotic to use, the frequency of redosing, par- 
ticularly in the intraoperative phase, the duration, and 
the standard regimens for non-routinary situations. 
In 1978 Kaiser et al. documented the efficacy of 
cefazolin to prevent surgical wound infection in vas- 
cular surgery when compared to placebo. The infection 
rate was 0.9% in the cefazolin group and 6.8% in 
the placebo group. 1 This difference was attributable 
entirely to the prevention of infection by cefazolin- 
susceptible strains, whereas the incidence of infection 
by cefazolin-resistant pathogens was similar in both 
regimens. Cefazolin is a first generation cephalosporin. 
Based on low toxicity, broad antimicrobial activity, 
including most Gram-negative bacilli, and the good 
antistaphylococcal activity, with the exclusion of ox- 
acillin-resistant strains, first and second generation 
cephalosporins are the dominant choice for vascular 
surgery. 
The success of prophylaxis correlates directly with 
the susceptibility of the pathogens to the selected 
antibiotic. Coagulase-negative staphylococci and 
Staphylococcus aureus were the leading pathogens 
among 26 vascular infections that occurred in our 
institution, and Gram-negative bacilli were responsible 
for one-third of infections. 2 Similar data are reported 
from many other institutions. 3'4 In our hospital, 79% of 
coagulase-negative staphylococci isolated from blood 
and 57.4% of coagulase-negative staphylococci isolated 
from surgical wounds in cardiovascular patients were 
oxacillin-resistant. A high incidence of oxacillin re- 
sistance was also recovered among S. aureus strains 
isolated in our hospital (63.1%), in community hos- 
pitals (42%) and in the community (8%). 5 The higher 
incidence of oxacillin-resistant strains was docu- 
mented in surgical wards, particularly in cardiac and 
neurosurgery wards. Oxacillin-resistant strains are 
also resistant o many other antibiotics; in our series 
only netilmicin and cotrimoxazole showed a good 
activity towards oxacillin-resistant S. aureus and van- 
comycin was the only constantly effective antibiotic. 6 
Due to the high incidence of resistant strains, ce- 
phalosporins can fail to prevent postoperative infection 
in this setting. 7 In 1992 Maki et al. 8 documented a 
greater activity of vancomycin to prevent surgical 
wound infections when compared to cefazolin and 
cefamandole (infection rate of 3.7%, 12.3% and 11.5%, 
respectively). The incidence of adverse effects was 
comparable for the three prophylactic regimens, with 
the exception of hypotension, which occurred more 
frequently in the group receiving vancomycin. This 
complication, often associated with rapid infusions of 
antibiotic, usually occurred at the first dose and re- 
quired withdrawal of vancomycin in only three cases. 
Cutaneous colonisation by oxacillin-resistant, co- 
agulase-negative staphylococci was significantly 
higher in patients receiving cefazolin prophylaxis than 
in the cefamandole and vancomycin group. Based 
on these data, vancomycin should be preferred to 
cephalosporins for perioperative prophylaxis in all 
patients with history of hypersensitivity to betalactam 
antibiotics or recently treated with broad spectrum 
antibiotics, in all patients undergoing raft vascular 
surgery, and for any operation in centres with a high 
incidence of surgical infections due to oxacillin-re- 
sistant staphylococci and enterococci. 8 Patients re- 
ceiving vancomycin should be pretreated with an H1 
histamine receptor antagonist, should receive van- 
comycin infusion for at least I h, and the infusion 
should be completed before anaesthetic ad- 
ministration. To reduce the emergence ofvancomycin- 
resistant strains, postoperative administration should 
be stringently limited to 24 h. On the basis of local 
epidemiological data standard regimens of peri- 
operative antibiotic prophylaxis in elective abdominal 
vascular surgery can include cefamandole or van- 
comycin, combined with an aminoglycoside if the risk 
of Gram-negative infection is considerable. 
To ensure adequate protection during surgery, thera- 
peutic serum and tissue levels of antibiotic must be 
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maintained throughout the surgical procedure. In 
patients undergoing cardiopulmonary b pass, blood 
levels of cefazolin, cefamandole and vancomycin de- 
crease progressively; in particular, at commonly used 
doses, vancomycin serum concentration at the com- 
pletion of bypass is not bactericidal for many sta- 
phylococcal strains,  Therefore, in this group of 
patients a higher initial dose of vancomycin (15 rag/ 
kg) and an intraoperative r dosing of 10 mg/kg at the 
end of bypass are suggested. 9 Intraoperative r dosing 
could also be useful in patients undergoing cardio- 
pulmonary bypass and receiving perioperative pro- 
phylaxis with cephalosporin, and in all patients 
receiving prophylaxis with antibiotics with short half- 
lives and undergoing prolonged (more than twice the 
antibiotic half-life) surgical procedures. 1° 
A particular egimen of perioperative antibiotic 
prophylaxis is suggested for thoraco-abdominal 
aneurysmectomy. In this surgical procedure cardio- 
pulmonary bypass is required, and the prolonged 
colonic ischaemia frequently permits entry of enteric 
micro-organisms. For this procedure preoperative oral 
prophylaxis with neomycin and erythromycin starting 
the evening before surgery, the intraoperative redosing 
of antibiotic, and the combination of an amino- 
glycoside are suggested. 
Antibiotics given preoperatively and intra- 
operatively are often continued for several days into 
the postoperative p riod. This practice represents he 
most controversial rea of antimicrobial prophylaxis. 
In 1977, Goldmann et al. 11 compared a 2-day regimen 
and a 6-day regimen of prophylaxis with cephalothin 
and documented a similar infection rate, with the only 
exception of urinary tract infections, less frequent in 
the 6-day regimen, but often due to resistant strains. 
Many other studies comparing short-course versus 
long-course prophylaxis have documented noincrease 
in infection rates among the short-course r cipients, 
and perioperative antibiotic prophylaxis hould not 
exceed 24 h. 12-I4 
A standard regimen of prophylaxis for extra-routine 
situations, such as surgery in patients with active 
infections of distant sites, emergency surgery, or early 
re-exploration for postoperative bleeding is not avail- 
able. The efficacy of alternative prophylactic regimens, 
including topical antibiotics, graft-bonded antibiotics 
and perioperative immunoglobulins are still under 
investigation. Is-Is 
In conclusion, vancomycin represents an alternative 
to first and second generation cephalosporins in the 
centres where oxacillin-resistant staphylococci are the 
prevalent pathogens. The addition of an amino- 
glycoside is suggested if Gram-negative bacilli wound 
contamination is probable. Intraoperative redosing 
and preoperative oral prophylaxis are required in 
thoracoabdominal aneurysmectomy. Further studies 
are necessary to determine regimens for extra-routine 
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